What Questions Will a Provider Ask Before Prescribing a GLP-1?
Author
glp winnerDate Published
- Twitter
- Facebook
- LinkedIn
- Instagram
- Copy Link
Quick catch-up. Before a clinician writes a prescription for a GLP-1 medication, they’re trying to see whether it’s safe and appropriate for your body and your medical picture. It’s not just “do you want one.” Your personal experience may vary, so this is general education you can bring to a conversation with your provider.
What questions does a provider ask before prescribing a GLP-1?
Before prescribing a GLP-1 medication, providers ask a set of medical questions to confirm safety, eligibility, and whether the medication fits your health profile. The goal is to determine medical appropriateness, not simply interest in the medication (Wegovy Prescribing Information, FDA).
Will a provider ask why I want a GLP-1?
Yes. Providers start by confirming the medical reason a GLP-1 is being considered. Some GLP-1 medications are FDA-approved for chronic weight management, while others are approved for type 2 diabetes, and those approved uses determine eligibility criteria and prescribing guidance (Wegovy Prescribing Information, FDA; Ozempic Prescribing Information, FDA).
Will a provider ask about my height, weight, or BMI?
Yes. Providers typically ask for height and weight to calculate BMI. BMI is one of the clinical criteria used when considering GLP-1 medications for chronic weight management, though it is not the only factor in prescribing decisions (Wegovy Prescribing Information, FDA).
Will a provider ask about my medical history?
Yes. Medical history is a key part of GLP-1 prescribing. Providers routinely ask about current and past medical conditions that could affect safety, including gastrointestinal disorders, endocrine conditions, and previous reactions to medications (Wegovy Prescribing Information, FDA; Ozempic Prescribing Information, FDA).
Will a provider ask about my family medical history?
Yes. Family medical history matters because certain rare conditions are listed as contraindications for some GLP-1 medications. Providers commonly ask about a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, which are specifically noted in FDA-approved labeling (Wegovy Prescribing Information, FDA).
Will a provider ask about medications or supplements I’m taking?
Yes. Providers ask about all current medications, including prescriptions, over-the-counter drugs, and supplements. This helps identify potential interactions and ensures GLP-1 therapy fits safely into your overall treatment plan (Ozempic Prescribing Information, FDA).
Will a provider ask if I’m pregnant or breastfeeding?
Yes. Pregnancy and breastfeeding status are always reviewed. GLP-1 medications are not recommended during pregnancy or while breastfeeding, so providers ask directly to avoid potential risks (Wegovy Prescribing Information, FDA).
Will a provider ask about my past weight-loss attempts?
Often, yes. Providers may ask about lifestyle changes, prior medications, or other weight-loss treatments you’ve tried. This helps them understand your history and determine whether a GLP-1 fits appropriately into your care plan (Wegovy Prescribing Information, FDA).
Are the screening questions different for compounded GLP-1 prescriptions?
The screening questions are usually similar. Providers still evaluate diagnosis, medical history, contraindications, and overall appropriateness. Compounded GLP-1 medications are not FDA-approved finished drugs, though compounding pharmacies themselves are regulated and inspected by the FDA. Prescribing decisions rely on clinician judgment and medical review (FDA Guidance on Compounded GLP-1 Drugs).
What questions are providers NOT asking when prescribing GLP-1s?
Providers are generally not asking:
- Whether you “deserve” the medication
- Whether you failed hard enough at dieting
- Whether weight loss is about willpower
- Whether you plan to eat perfectly forever
The focus stays on medical safety, eligibility, and whether the treatment makes sense for your health.
Do providers always require a medical questionnaire before prescribing GLP-1s?
Yes. Medical questionnaires or intake forms are standard because GLP-1 medications require evaluation of eligibility, contraindications, and safety before prescribing (Wegovy Prescribing Information, FDA).
Can a provider say no even if I meet BMI criteria when prescribing a GLP-1?
Yes. Meeting BMI criteria alone does not guarantee a prescription for a GLP-1. Providers must consider the full medical picture, including medical history and potential risks (Wegovy Prescribing Information, FDA).
Why do providers ask so many detailed questions about GLP-1s?
GLP-1 medications affect appetite, digestion, and hormone signaling. Because they interact with multiple body systems, providers are required to screen for risks and contraindications before prescribing (Ozempic Prescribing Information, FDA).
What this means for you
If a provider asks a lot of questions before prescribing a GLP-1, that’s a good sign. It means they’re taking the time to understand your health, reduce risk, and make sure any treatment decision is thoughtful and appropriate for you long-term.
If you enjoy posts like these, you can subscribe to receive newsletter updates.
Sources
Keep Reading
Worried about GLP-1 side effects like stomach paralysis or “Ozempic face”? This guide debunks myths with real research and clear answers.
New GLP-1 trial data shows what often happens after stopping Ozempic, Wegovy, Mounjaro, or Zepbound and how to plan a safer exit with your clinician.
Learn how much protein you need on a GLP-1 medication, why it protects muscle, and how to hit your daily target even with a lower appetite.
Categories
Curated by
